カイジェンは、大正製薬とこの独占的ライセンス契約を締結しました。これは、同社の次世代自己免疫疾患治療薬「KG006」の開発および、特に日本における商業化を支援することを目的としています。つまり、基本的にはこの契約に基づき……
bitBiome, Inc., a biotechnology company unlocking the potential of our planet's microbes…
Fujirebio, a leading innovator in in-vitro diagnostics, announced a collaboration with Stanford Medicine…
ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal…
Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui…
Alloy Therapeutics Inc., a biotechnology ecosystem company dedicated to democratizing access to…
RevolKa Ltd., a venture-backed biotech company providing a cutting-edge AI-driven protein engineering…
FUJIFILM Corporation announces the successful validation of the cancer cell-targeting potential of…
Asahi Kasei Bioprocess America (AKBA) and PeptiSystems have formed an exclusive global…
bitBiome, Inc., a biotechnology company unlocking the potential of our planet's microbes…
Fujirebio, a leading innovator in in-vitro diagnostics, announced a collaboration with Stanford Medicine…
ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal…
Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui…
Alloy Therapeutics Inc., a biotechnology ecosystem company dedicated to democratizing access to…
RevolKa Ltd., a venture-backed biotech company providing a cutting-edge AI-driven protein engineering…
FUJIFILM Corporation announces the successful validation of the cancer cell-targeting potential of…
Asahi Kasei Bioprocess America (AKBA) and PeptiSystems have formed an exclusive global…
アカウントにサインインする